TWO SIGMA ADVISERS, LP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$355,093
+48.0%
22,517
+423.7%
0.00%0.0%
Q3 2021$240,000
-79.3%
4,300
-84.1%
0.00%
-66.7%
Q2 2021$1,160,000
-75.1%
27,100
-75.7%
0.00%
-76.9%
Q1 2021$4,662,000
+22.1%
111,700
+36.2%
0.01%
+30.0%
Q4 2020$3,819,000
+495.8%
82,000
+443.0%
0.01%
+400.0%
Q3 2020$641,000
+15.1%
15,100
+30.2%
0.00%0.0%
Q2 2020$557,000
-5.6%
11,600
+9.4%
0.00%
+100.0%
Q2 2019$590,000
+82.7%
10,600
+65.6%
0.00%0.0%
Q1 2019$323,000
-28.9%
6,400
+6.7%
0.00%0.0%
Q2 2018$454,000
+58.7%
6,000
+25.0%
0.00%0.0%
Q3 2017$286,000
+10.0%
4,800
+45.5%
0.00%0.0%
Q2 2017$260,000
-92.0%
3,300
-91.0%
0.00%
-94.7%
Q4 2015$3,236,000
-27.6%
36,491
-39.4%
0.02%
-32.1%
Q3 2015$4,470,000
+407.4%
60,200
+452.3%
0.03%
+300.0%
Q2 2015$881,00010,9000.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders